Faculty of Medicine, Department of Biomedical Imaging, University of Malaya Research Imaging Centre, Universiti Malaya, Kuala Lumpur, Malaysia.
Faculty of Medicine, Department of Radiology, Universiti Teknologi MARA, Sg Buloh, Malaysia.
PLoS One. 2024 Aug 29;19(8):e0309131. doi: 10.1371/journal.pone.0309131. eCollection 2024.
Accurate subtyping of breast cancer is crucial for its diagnosis, management, and prognostication. This study aimed to determine the association of magnetic resonance imaging (MRI) breast features with the molecular subtype and aggressiveness of breast cancer in a multi-ethnic population.
Treatment-naive patients with invasive breast carcinoma were included in this retrospective study. Breast MRI features were recorded based on the American College of Radiology-Breast Imaging Reporting and Data System (ACR-BIRADS) criteria, with tumour size, and apparent diffusion coefficient value (ADC). The statistical association was tested with Pearson Chi-Square Test of Independence for categorical data or the Kruskal-Wallis/ Mann Whitney U test for numerical data between the MRI features and molecular subtype, receptor status, tumour grade, lymphovascular infiltration (LVI) and axillary lymph node (ALN). Multinomial logistic regression was used to test the predictive likelihood of the significant features. The breast cancer subtypes were determined via immunohistochemistry (IHC) and dual-color dual-hapten in-situ hybridization (D-DISH). The expression statuses of ER, PR, and HER-2, LVI, and ALN were obtained from the histopathology report. The ER / PR / HER-2 was evaluated according to the American Society of Clinical Oncology / College of American Pathologists.
The study included 194 patients; 41.8% (n = 81) Chinese, 40.7% (n = 79) Malay, and 17.5% (n = 34) Indian, involving 71.6%(n = 139) luminal-like, 12.9%(n = 25) HER-2 enriched, and 15.5%(n = 30) Triple-negative breast cancer (TNBC). TNBC was associated with rim enhancement (p = 0.002) and peritumoral oedema (p = 0.004). HER-2 enriched tumour was associated with larger tumour size (p = 0.041). Luminal-like cancer was associated with irregular shape (p = 0.005) with circumscribed margin (p = 0.003). Other associations were ER-negative tumour with circumscribed margin (p = 0.002) and PR-negative with round shape (p = 0.001). Tumour sizes were larger in ER-negative (p = 0.044) and PR-negative (p = 0.022). Rim enhancement was significantly associated with higher grade (p = 0.001), and moderate peritumoral oedema with positive axillary lymph node (p = 0.002).
Certain MRI features can be applied to differentiate breast cancer molecular subtypes, receptor status and aggressiveness, even in a multi-ethnic population.
准确的乳腺癌分型对于其诊断、治疗和预后至关重要。本研究旨在探讨磁共振成像(MRI)乳腺特征与多民族人群乳腺癌分子亚型和侵袭性的关系。
本回顾性研究纳入了未经治疗的浸润性乳腺癌患者。根据美国放射学院-乳腺成像报告和数据系统(ACR-BIRADS)标准记录乳腺 MRI 特征,包括肿瘤大小和表观扩散系数值(ADC)。采用 Pearson 卡方检验独立性或 Kruskal-Wallis/Mann-Whitney U 检验对 MRI 特征与分子亚型、受体状态、肿瘤分级、脉管浸润(LVI)和腋窝淋巴结(ALN)之间的数值数据进行统计学关联检验。采用多变量逻辑回归检验有意义特征的预测可能性。通过免疫组化(IHC)和双色双半原位杂交(D-DISH)确定乳腺癌亚型。ER、PR 和 HER-2、LVI 和 ALN 的表达状态从组织病理学报告中获得。ER/PR/HER-2 根据美国临床肿瘤学会/美国病理学家协会进行评估。
研究纳入 194 例患者;41.8%(n=81)为中国人,40.7%(n=79)为马来人,17.5%(n=34)为印度人,涉及 71.6%(n=139)为管腔样、12.9%(n=25)为 HER-2 富集和 15.5%(n=30)为三阴性乳腺癌(TNBC)。TNBC 与边缘强化(p=0.002)和瘤周水肿(p=0.004)相关。HER-2 富集肿瘤与较大的肿瘤大小相关(p=0.041)。管腔样癌症与不规则形状(p=0.005)和边界清晰(p=0.003)相关。其他关联包括 ER 阴性肿瘤与边界清晰(p=0.002)和 PR 阴性与圆形(p=0.001)。ER 阴性(p=0.044)和 PR 阴性(p=0.022)肿瘤的肿瘤体积更大。边缘强化与较高的分级显著相关(p=0.001),中度瘤周水肿与阳性腋窝淋巴结相关(p=0.002)。
即使在多民族人群中,某些 MRI 特征也可用于区分乳腺癌的分子亚型、受体状态和侵袭性。